tiprankstipranks
Revolution Medicines announces $600M common stock offering
PremiumThe FlyRevolution Medicines announces $600M common stock offering
16d ago
Revolution Medicines price target raised to $80 from $70 at Stifel
Premium
The Fly
Revolution Medicines price target raised to $80 from $70 at Stifel
16d ago
Revolution Medicines provides updates from RAS(ON) inhibitor combo studies
Premium
The Fly
Revolution Medicines provides updates from RAS(ON) inhibitor combo studies
16d ago
Revolution Medicines price target raised to $64 from $62 at H.C. Wainwright
PremiumThe FlyRevolution Medicines price target raised to $64 from $62 at H.C. Wainwright
1M ago
Revolution Medicines Reports Q3 2024 Results and Progress
Premium
Company Announcements
Revolution Medicines Reports Q3 2024 Results and Progress
1M ago
Revolution Medicines reports Q3 EPS (94c), consensus (89c)
Premium
The Fly
Revolution Medicines reports Q3 EPS (94c), consensus (89c)
1M ago
Revolution Medicines data validates RMC-6236’s anti-tumor activity, says Wedbush
PremiumThe FlyRevolution Medicines data validates RMC-6236’s anti-tumor activity, says Wedbush
2M ago
Revolution Medicines presents data from RMC-6236 Monotherapy Study
Premium
The Fly
Revolution Medicines presents data from RMC-6236 Monotherapy Study
2M ago
Revolution Medicines: 1st patient dosed in RMC-6236 study for PDAC treatment
Premium
The Fly
Revolution Medicines: 1st patient dosed in RMC-6236 study for PDAC treatment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100